Back to CITADEL ADVISORS LLC

DNTH
8 quarters

Position history for CITADEL ADVISORS LLC's holdings in DIANTHUS THERAPEUTICS INC

CITADEL ADVISORS LLC holds 1.6M shares of DNTH (DIANTHUS THERAPEUTICS INC), worth $135.2M as of 2026-Q1. The position was increased (+50.7% shares). DNTH represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$135.2M

Current Shares

1.6M

Total Value Change

+$135.2M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.6M
+50.7%
$135.2M0.0%$55.39
42
2025-Q4
Increased
1.1M
+5.5%
$44.1M0.0%$40.96
31
2025-Q3
Increased
1M
+52.4%
$39.9M0.0%$39.55
41
2025-Q2
Increased
665,044
+41.2%
$12.4M0.0%$17.63
37
2025-Q1
Increased
470,880
+11.6%
$8.5M0.0%$19.99
31
2024-Q4
Increased
422,038
+611.7%
$9.2M0.0%$21.50
45
2024-Q3
New
59,301
-
$1.6M0.0%$27.24
35
2024-Q2
Exited
0
-100.0%
$00.0%$25.88
0

Other major holders of DNTH: FMR LLC, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used